Suppression of macrophages- Induced inflammation via targeting RAS and PAR-4 signaling in breast cancer cell lines.

In conclusion, our data support the role of piroxicam and sulindac sulfide in suppressing inflammation-driven breast cancer progression and identifies promising novel target in RAS and PAR-4 signaling. PMID: 31678245 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31678245?dopt=Abstract

Source: Toxicology and Applied Pharmacology - October 29, 2019 Category: Toxicology Authors: Thabet NA, El-Guendy N, Mohamed MM, Shouman SA Tags: Toxicol Appl Pharmacol Source Type: research